Latest Forum Topics /
IX Biopharma
Last:0.355
+0.01
|
 Post Reply
|
|
iX Biopharma
|
||||||
|
ahberngh
Elite |
16-Aug-2023 12:53
|
|||||
|
x 0
x 0 Alert Admin |
Their WaferIX drug delivery platform and ongoing enhancements to it is their most valuable asset, I think. There is an outside chance that they could be a target for big pharma in future. Just my opinion, please dyodd. |
|||||
| Useful To Me Not Useful To Me | ||||||
|
SmallSmall
Supreme |
16-Aug-2023 11:49
|
|||||
|
x 0
x 0 Alert Admin |
Not much resistance to $0.07-$0.08 where it dropped from in July 2013. Only news was athe issuance of a $2 mil CB in July but the shares are only convertible at $0.13.
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
|
||||||
|
GGTTAANN
Senior |
16-Aug-2023 11:42
|
|||||
|
x 0
x 0 Alert Admin |
https://investors.sgx.com/company-disclosures/company-announcements?securityCode=42C Read yourself |
|||||
| Useful To Me Not Useful To Me | ||||||
|
SmallSmall
Supreme |
16-Aug-2023 11:20
|
|||||
|
x 0
x 0 Alert Admin |
Up 36%. Can go to 50%? Illquid stock that crashed from $0.20 plus cts
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
ahberngh
Elite |
16-Aug-2023 11:20
|
|||||
|
x 0
x 0 Alert Admin |
Could be why up today! These two days drop to as low as 3.8c. Hope it is not just a dead cat bounce. This company have many promising products but getting approval and marketing very slow. Only for long term investors, contras and short term players should stay away.
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
|
||||||
|
GGTTAANN
Senior |
16-Aug-2023 09:29
|
|||||
|
x 0
x 0 Alert Admin |
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
cherintc
Senior |
04-Aug-2023 21:36
|
|||||
|
x 0
x 0 Alert Admin |
IX Biopharma Issues SG$2 Million Worth of Convertible Bonds to Private Investor.This is the death roll. The lower the share price, the bigger the dilution which in turn cause the share price to drop further. |
|||||
| Useful To Me Not Useful To Me | ||||||
|
ahberngh
Elite |
04-Aug-2023 16:35
|
|||||
|
x 0
x 0 Alert Admin |
Aiyah, SGX is a sinking ship, most shares are drifting down and down..... | |||||
| Useful To Me Not Useful To Me | ||||||
|
|
||||||
|
ahberngh
Elite |
04-Aug-2023 16:25
|
|||||
|
x 0
x 0 Alert Admin |
Seelos has risen to the 1.5-1.6 region. Data coming out in 2-3 weeks on their SLS-002 Phase 2 trials, people expecting good results. Don' t know why IX hitting new lows everyday, shortists pushing down or expecting poor H2 results. |
|||||
| Useful To Me Not Useful To Me | ||||||
|
7ocean
Master |
04-Aug-2023 13:58
|
|||||
|
x 0
x 0 Alert Admin |
When was the result announcements?
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
newbie1118
Master |
04-Aug-2023 13:10
|
|||||
|
x 0
x 0 Alert Admin |
So scary. Everyday touching new low. | |||||
| Useful To Me Not Useful To Me | ||||||
|
7ocean
Master |
14-Mar-2023 16:23
|
|||||
|
x 0
x 0 Alert Admin |
She can save others, but not her own stocks
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
|
||||||
|
cherintc
Senior |
14-Mar-2023 15:29
|
|||||
|
x 0
x 0 Alert Admin |
broke 0.1, another rude awakening. | |||||
| Useful To Me Not Useful To Me | ||||||
|
newbie1118
Master |
18-Jan-2023 08:38
|
|||||
|
x 0
x 0 Alert Admin |
Shares of SEEL jumped 14.3% in Nasdaq closed above $1. Will it help IX share price today?
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
newbie1118
Master |
14-Jan-2023 09:25
|
|||||
|
x 0
x 0 Alert Admin |
Seelos Therapeutics (SEEL) listed in Nasdaq which IX has a substantial shares in it has been on an uptrend since the beginning of the year rallies from a low of US$0.64 to US$0.90 which is a 50% increase. Hopefully IX will benefit from this uptrend too in it' s share price in the near future to break the multi year low downtrend cycle. | |||||
| Useful To Me Not Useful To Me | ||||||
|
newbie1118
Master |
06-Jan-2023 12:13
|
|||||
|
x 0
x 0 Alert Admin |
Recent placement shares is at $0.20. So capital is not a problem in the near future. Phillip Securities has a price target of $0.25. At this price I think it' s a very good price to accumulate. Disadvantages is the low volume shares traded. But this will change once investor has more confidence in their earning recovery. DYDD.
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
ahberngh
Elite |
06-Jan-2023 11:58
|
|||||
|
x 0
x 0 Alert Admin |
Yes, possible multibagger if their products/drugs take off. But contra and short term traders avoid, not going to happen in your time frame. Just my opinion, please dyodd. Vested for the longer term.
|
|||||
| Useful To Me Not Useful To Me | ||||||
|
newbie1118
Master |
06-Jan-2023 11:52
|
|||||
|
x 0
x 0 Alert Admin |
Company still in infancy stages. Huge prospect to grow bigger in the near future. | |||||
| Useful To Me Not Useful To Me | ||||||
|
newbie1118
Master |
29-Dec-2022 17:16
|
|||||
|
x 0
x 0 Alert Admin |
Strong close. Something brewing? | |||||
| Useful To Me Not Useful To Me | ||||||
|
Wind888
Senior |
27-Oct-2022 23:16
|
|||||
|
x 0
x 0 Alert Admin |
IX BIOPHARMASingapore, 21 October 2022 &ndash Specialty pharmaceutical company iX Biopharma Ltd (SGX:42C), is pleased to announce that its has won the &ldquo Best CBD (Sublingual) Edible&rdquo award&rdquo at the 2022 World CBD Awards ceremony in Barcelona, Spain last night.The awards ceremony is a highlight of the World CBD B2B Expo and Conference, and celebrates the best-in-class in the CBD and Hemp industry for their standards, excellence, and achievements by recognising companies that go the extra mile to make the industry a safe and respected place, and operate their business with integrity, transparency and ethics.
Products nominated for the awards undergo a rigorous judging process employing lab report results, research panel reports, physical testing, application, and supporting documents as well as an aesthetics and safety report. The benchmarks are thoroughly examined by and independent panel of qualified and respected scientists, physicians, and professionals who are experts in the CBD or Hemp industry.
On winning the award, iX Biopharma Chief Commercial Officer Eva Tan, said, &ldquo We were up against strong contenders from other sublinguals including tinctures for this award and we are proud that XativaTM has risen above its competition to emerge at the top. The CBD industry is one of the fastest growing sectors, propelled by rising public demand and the rapidly changing perceptions about the therapeutic potential of the cannabis plant. This award affirms that XativaTM is clearly differentiated in the market, and we are determined to leverage this momentum for sustainable growth.&rdquo
|
|||||
| Useful To Me Not Useful To Me | ||||||